A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs
Related Experiment Video
Updated: Oct 6, 2025

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
Ningning Tang1, Ling Li1, Fei Xie1
1College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, China.
Abstract:
Suppression of cellular O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) can repress proliferation and migration of various cancer cells, which opens a new avenue for cancer therapy. Based on the regulation of insulin gene transcription, we designed a cell-based fluorescent reporter capable of sensing cellular O-GlcNAcylation in HEK293T cells. The fluorescent reporter mainly consists of a reporter (green fluorescent protein (GFP)), an internal reference (red fluorescent protein), and an operator (neuronal differentiation 1), which serves as a "sweet switch" to control GFP expression in response to cellular O-GlcNAcylation changes. The fluorescent reporter can efficiently sense reduced levels of cellular O-GlcNAcylation in several cell lines. Using the fluorescent reporter, we screened 120 natural products and obtained one compound, sesamin, which could markedly inhibit protein O-GlcNAcylation in HeLa and human colorectal carcinoma-116 cells and repress their migration in vitro. Altogether, the present study demonstrated the development of a novel strategy for anti-tumor drug screening, as well as for conducting gene transcription studies.
Insights
A novel fluorescent reporter detects cellular O-linked β-N-acetylglucosaminylation (O-GlcNAcylation), aiding cancer therapy research. This tool identified sesamin, a compound that inhibits O-GlcNAcylation and cancer cell migration.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cellular O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) plays a role in regulating cancer cell proliferation and migration.
- Targeting O-GlcNAcylation presents a potential therapeutic strategy for cancer treatment.
Purpose of the Study:
- To develop a cell-based fluorescent reporter system for sensing cellular O-GlcNAcylation levels.
- To utilize this reporter system for screening natural products as potential anti-cancer agents.
Main Methods:
- Designed a fluorescent reporter using green fluorescent protein (GFP), red fluorescent protein, and neuronal differentiation 1, linked to insulin gene transcription regulation.
- Validated the reporter's ability to detect reduced O-GlcNAcylation in various cell lines.
- Screened 120 natural products using the developed reporter system.
Main Results:
- The fluorescent reporter system successfully sensed changes in cellular O-GlcNAcylation.
- Sesamin was identified as a compound that significantly inhibits O-GlcNAcylation in HeLa and human colorectal carcinoma-116 cells.
- Sesamin demonstrated the ability to repress cancer cell migration in vitro.
Conclusions:
- Developed a novel fluorescent reporter for monitoring O-GlcNAcylation, applicable to gene transcription studies.
- Identified sesamin as a potential anti-cancer compound through a high-throughput drug screening strategy.
- The study provides a new approach for anti-tumor drug discovery and O-GlcNAcylation research.
More Related Videos
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022